Contractors / Glaxosmithkline, LLC
Glaxosmithkline, LLC
prime recipient of federal awards · UEI FRHTPHMZMX47 ✓ from source
$850.1M
obligated · FY2023
5
funding agencies
100%
from Health and Hum…
8
states
1%
in Georgia
8
industries
Obligations by year
≈ computed$850.1M
FY23
$1.2B
FY24
$980.5M
FY25
▲ 15%
since FY23
Where this money comes from
✓ from sourceFUNDING AGENCIES
GLAXOSMITHKLINE, LLC
HHS
$0.9B
Glaxosmithkline, LLC
$0.9B
FY2023 obligated
Biggest awards (total value)
awarded 2021$1.6B
awarded 2017$682.2M
awarded 2020$335.6M
Total value over each award’s life, for awards active in FY2023: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
Georgia✓ from source$8.7M
Pennsylvania✓ from source$4.7M
Virginia✓ from source$583.3K
Illinois✓ from source$120.5K
Texas✓ from source$3.4K
Competitors
Mckesson Corporation≈ computed$11.9B
Sanofi Vaccines US Inc.≈ computed$1B
Pfizer Inc≈ computed$700.6M
Alvogen, Inc.≈ computed$227.7M
Bavarian Nordic A/S≈ computed$143.6M
DMS Pharmaceutical Group Inc≈ computed$4.3M
Baylor College of Medicine≈ computed$3.1M
Trillamed LLC≈ computed$1.5M
computed from shared NAICS, not a stated rivalry.
Corporate family
Single registration: no combined family.
Political contributions
Glaxosmithkline LLC PAC (Gsk PAC)gave$144Kto members of Congress, 2024 cycle✓ from source
linked through public filings, not a claim of coordination. contribution reported to the FEC, a public campaign-finance record.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.